Product Information
LOPINAVIR-RITONAVR 200-50 MG TB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $4.4210 per EA under NDC 31722055612. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
200; 50 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722055612
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LOPINAVIR; RITONAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA091677On Market Since
6/7/2021
Pharmacological Classes
Price Statistics
The NADAC for LOPINAVIR-RITONAVR 200-50 MG TB has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4210 per EA |
|---|---|
| All-time high | $5.3737 (Dec 11, 2024) |
| All-time low | $4.1706 (Jun 19, 2024) |
| 52-week high | $5.2427 |
| 52-week low | $4.3788 |
| Median price | $4.6021 |
| Average price | $4.6320 |
| Largest weekly change | +15.8% (Nov 20, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Lopinavir and ritonavir market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LOPINAVIR-RITONAVR 200-50 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for LOPINAVIR-RITONAVR 200-50 MG TB, manufactured by Camber Pharmaceuticals Inc., is $4.4210 per EA (NDC 31722055612), effective Jun 24, 2026.
How has the price of LOPINAVIR-RITONAVR 200-50 MG TB changed over time?
Over the history we have for it, the NADAC for LOPINAVIR-RITONAVR 200-50 MG TB has declined 8.9%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LOPINAVIR-RITONAVR 200-50 MG TB?
Since Apr 17, 2024, the NADAC for LOPINAVIR-RITONAVR 200-50 MG TB has ranged from a low of $4.1706 (Jun 19, 2024) to a high of $5.3737 (Dec 11, 2024), with a median of $4.6021 per EA.
Are there cheaper alternatives to LOPINAVIR-RITONAVR 200-50 MG TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LOPINAVIR-RITONAVR 200-50 MG TB, so no direct lower-cost alternative is listed.
Who manufactures LOPINAVIR-RITONAVR 200-50 MG TB?
LOPINAVIR-RITONAVR 200-50 MG TB (NDC 31722055612) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification